Cost effectiveness analysis comparing continuation of assisted reproductive technology with conversion to intrauterine insemination in patients with low follicle numbers

In patients with 4 mature follicles during controlled ovarian stimulation, it is more cost effective to proceed with oocyte retrieval than to convert to intrauterine insemination.

Like Comment


Bo Yu, M.D., Sunni Mumford, Ph.D., G. Donald Royster IV, M.D., James H. Segars, M.D., Alicia Y. Armstrong, M.D.

Volume 102, Issue 2, Pages 435–439



To compare the cost effectiveness of proceeding with oocyte retrieval vs. converting to intrauterine insemination (IUI) in patients with ≤4 mature follicles during assisted reproductive technology (ART) cycles.


Probabilistic decision analysis. The cost effectiveness of completing ART cycles in poor responders was compared to that for converting the cycles to IUI.


Not applicable.


Not applicable.


Cost-effectiveness analysis.

Main Outcome Measure(s):

Cost effectiveness, which was defined as the average direct medical costs per ongoing pregnancy.


In patients with 1–3 mature follicles, completing ART was more cost effective if the cost of a single ART cycle was between $10,000 and $25,000. For patients with 4 mature follicles, if an ART cycle cost <$18,025, it was more cost effective to continue with oocyte retrieval than to convert to IUI. Conclusion(s):

In patients with ≤4 mature follicles following ovarian stimulation in ART cycles, it was on average more cost effective to proceed with oocyte retrieval rather than convert to IUI. However, important factors, such as age, prior ART failures, other fertility factors, and medications used in each individual case need to be considered before this analysis model can be adapted by individual practices.

Read the full text at:

Fertility and Sterility

Editorial Office, American Society for Reproductive Medicine

Fertility and Sterility® is an international journal for obstetricians, gynecologists, reproductive endocrinologists, urologists, basic scientists and others who treat and investigate problems of infertility and human reproductive disorders.